Tarnagulla Ventures logo

Tarnagulla Ventures

Oceania, Victoria, Australia, Melbourne

Description

Tarnagulla Ventures is a venture capital firm.

Investor Profile

Tarnagulla Ventures has backed more than 1 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 1 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series A rounds (top funding stages).
  • Majority of deals are located in Canada.
  • Strong thematic focus on Biopharma, Biotechnology, Health Care.

Stage Focus

  • Series A (100%)

Country Focus

  • Canada (100%)

Industry Focus

  • Biopharma
  • Biotechnology
  • Health Care
  • Medical
  • Pharmaceutical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Tarnagulla Ventures frequently co-invest with?

Amorchem
North America, Quebec, Canada, Montréal
Co-Investments: 1
Accel-Rx Health Sciences Accelerator
North America, British Columbia, Canada, Vancouver
Co-Investments: 1
AQC Capital
North America, Quebec, Canada, Montréal
Co-Investments: 1
The Foundation for Prader-Willi Research
North America, California, United States, Walnut
Co-Investments: 1
JDRF T1D Fund
North America, Massachusetts, United States, Boston
Co-Investments: 1
Genesys Capital
North America, Ontario, Canada, Toronto
Co-Investments: 1
Anges Quebec
North America, Quebec, Canada, Quebec
Co-Investments: 1

What are some of recent deals done by Tarnagulla Ventures?

Inversago Pharma

Montréal, Quebec, Canada

Inversago Pharma is a clinical stage biotech company with a unique portfolio of peripherally-acting CB1 inverse agonists

BiopharmaBiotechnologyHealth CareMedicalPharmaceutical
Series AJul 25, 2018
Amount Raised: $7,000,000